Boris Bastian - Publications

Affiliations: 
Pathology and Laboratory Medicine University of California, San Francisco, San Francisco, CA 

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Houlier A, Pissaloux D, Masse I, Tirode F, Karanian M, Pincus LB, McCalmont TH, LeBoit PE, Bastian BC, Yeh I, de la Fouchardière A. Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31719662 DOI: 10.1038/s41379-019-0384-8  0.36
2019 Botton T, Talevich E, Mishra VK, Zhang T, Shain AH, Berquet C, Gagnon A, Judson RL, Ballotti R, Ribas A, Herlyn M, Rocchi S, Brown KM, Hayward NK, Yeh I, ... Bastian BC, et al. Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. Cell Reports. 29: 573-588.e7. PMID 31618628 DOI: 10.1016/j.celrep.2019.09.009  0.36
2019 Torres R, Lang UE, Hejna M, Shelton SJ, Joseph NM, Shain AH, Yeh I, Wei ML, Oldham MC, Bastian BC, Judson-Torres RL. MicroRNA ratios distinguish melanomas from nevi. The Journal of Investigative Dermatology. PMID 31580842 DOI: 10.1016/j.jid.2019.06.126  0.36
2019 Rotow JK, Gui P, Wu W, Raymond VM, Lanman RB, Kaye FJ, Peled N, Fece de la Cruz F, Nadres B, Corcoran RB, Yeh I, Bastian BC, Starostik P, Newsom K, Olivas V, et al. Co-occurring alterations in the RAS-MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation-positive lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31548343 DOI: 10.1158/1078-0432.CCR-19-1667  0.32
2019 Newell F, Kong Y, Wilmott JS, Johansson PA, Ferguson PM, Cui C, Li Z, Kazakoff SH, Burke H, Dodds TJ, Patch AM, Nones K, Tembe V, Shang P, van der Weyden L, ... ... Bastian BC, et al. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nature Communications. 10: 3163. PMID 31320640 DOI: 10.1038/s41467-019-11107-x  0.32
2019 Tsai KK, Khurana N, McCalmont T, Daud A, Bastian B, Yeh I. PTCH1 Mutation in a Patient With Metastatic Undifferentiated Carcinoma With Clear Cell Change. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 778-783. PMID 31319387 DOI: 10.6004/jnccn.2019.7313  0.32
2019 Shain AH, Bagger MM, Yu R, Chang D, Liu S, Vemula S, Weier JF, Wadt K, Heegaard S, Bastian BC, Kiilgaard JF. The genetic evolution of metastatic uveal melanoma. Nature Genetics. PMID 31253977 DOI: 10.1038/s41588-019-0440-9  0.32
2019 Yeh I, Busam KJ, McCalmont TH, LeBoit PE, Pissaloux D, Alberti L, de la Fouchardière A, Bastian BC. Filigree-like Rete Ridges, Lobulated Nests, Rosette-like Structures, and Exaggerated Maturation Characterize Spitz Tumors With NTRK1 Fusion. The American Journal of Surgical Pathology. PMID 30844834 DOI: 10.1097/PAS.0000000000001235  0.36
2019 Wong K, van der Weyden L, Schott CR, Foote A, Constantino-Casas F, Smith S, Dobson JM, Murchison EP, Wu H, Yeh I, Fullen DR, Joseph N, Bastian BC, Patel RM, Martincorena I, et al. Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma. Nature Communications. 10: 353. PMID 30664638 DOI: 10.1038/s41467-018-08081-1  0.32
2019 Yeh I, Jorgenson E, Shen L, Xu M, North JP, Shain AH, Reuss D, Wu H, Robinson WA, Olshen A, von Deimling A, Kwok PY, Bastian BC, Asgari MM. Targeted genomic profiling of acral melanoma. Journal of the National Cancer Institute. PMID 30657954 DOI: 10.1093/jnci/djz005  0.36
2018 Ablain J, Xu M, Rothschild H, Jordan RC, Mito JK, Daniels BH, Bell CF, Joseph NM, Wu H, Bastian BC, Zon LI, Yeh I. Human tumor genomics and zebrafish modeling identify loss as a driver of mucosal melanoma. Science (New York, N.Y.). PMID 30385465 DOI: 10.1126/science.aau6509  0.32
2018 López GY, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Clarke J, Oberheim Bush NA, Taylor J, Chang S, Butowski N, Banerjee A, Mueller S, Kline C, Torkildson J, et al. The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathologica. PMID 30196423 DOI: 10.1007/s00401-018-1906-z  0.32
2018 Stevers M, Rabban JT, Garg K, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Zaloudek C, Solomon DA. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 30171198 DOI: 10.1038/s41379-018-0127-2  0.32
2018 Zeng H, Jorapur A, Shain AH, Lang UE, Torres R, Zhang Y, McNeal AS, Botton T, Lin J, Donne M, Bastian IN, Yu R, North JP, Pincus L, Ruben BS, ... ... Bastian BC, et al. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation. Cancer Cell. 34: 56-68.e9. PMID 29990501 DOI: 10.1016/j.ccell.2018.05.014  0.36
2018 Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, Ruben B, North J, Pincus L, Yeh I, Judson R, Bastian BC. Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. Cancer Cell. 34: 45-55.e4. PMID 29990500 DOI: 10.1016/j.ccell.2018.06.005  0.36
2018 Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, ... ... Bastian BC, et al. A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nature Communications. 9: 810. PMID 29476136 DOI: 10.1038/s41467-018-02826-8  0.36
2017 Goode B, Joseph NM, Stevers M, Van Ziffle J, Onodera C, Talevich E, Grenert JP, Yeh I, Bastian BC, Phillips JJ, Garg K, Rabban JT, Zaloudek C, Solomon DA. Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 29148537 DOI: 10.1038/modpathol.2017.153  0.36
2017 Foley N, Van Ziffle J, Yu J, Qi Z, Grenert JP, Yeh I, Bastian B, Kogan S, Mannis GN. Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation? Cancer Genetics. 216: 74-78. PMID 29025598 DOI: 10.1016/j.cancergen.2017.07.002  0.32
2017 Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la Fouchardière A. Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi. Nature Communications. 8: 644. PMID 28935960 DOI: 10.1038/s41467-017-00758-3  0.36
2017 Chiba K, Lorbeer FK, Shain AH, McSwiggen DT, Schruf E, Oh A, Ryu J, Darzacq X, Bastian BC, Hockemeyer D. Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science (New York, N.Y.). PMID 28818973 DOI: 10.1126/science.aao0535  0.32
2017 Shain AH, Bastian BC. Filling the gaps in the genomic catalogue of melanoma subtypes. Pigment Cell & Melanoma Research. PMID 28656717 DOI: 10.1111/pcmr.12612  0.32
2017 Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, Aboian M, Cha S, Raleigh DR, Braunstein S, Torkildson J, Samuel D, Bloomer M, Campomanes AGA, Banerjee A, ... ... Bastian BC, et al. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncology. 19: 699-709. PMID 28453743 DOI: 10.1093/neuonc/now254  0.36
2016 Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, Aboian M, Cha S, Raleigh DR, Braunstein S, Torkildson J, Samuel D, Bloomer M, Campomanes AG, Banerjee A, ... ... Bastian BC, et al. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncology. PMID 27978508 DOI: 10.1093/neuonc/now254  0.36
2016 Joseph NM, Chen YY, Nasr A, Yeh I, Talevich E, Onodera C, Bastian BC, Rabban JT, Garg K, Zaloudek C, Solomon DA. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27813512 DOI: 10.1038/modpathol.2016.188  0.36
2016 Yeh I, Tee MK, Botton T, Hunter Shain A, Sparatta AJ, Gagnon A, Vemula SS, Garrido MC, Nakamaru K, Isoyama T, McCalmont TH, LeBoit PE, Bastian BC. NTRK3 kinase fusions in Spitz tumours. The Journal of Pathology. PMID 27477320 DOI: 10.1002/path.4775  0.36
2016 Liu SY, Joseph NM, Ravindranathan A, Stohr BA, Greenland NY, Vohra P, Hosfield E, Yeh I, Talevich E, Onodera C, Van Ziffle JA, Grenert JP, Bastian BC, Chen YY, Krings G. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27255162 DOI: 10.1038/modpathol.2016.97  0.36
2016 Shain AH, Bastian BC. From melanocytes to melanomas. Nature Reviews. Cancer. 16: 345-58. PMID 27125352 DOI: 10.1038/nrc.2016.37  0.32
2016 Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing. Plos Computational Biology. 12: e1004873. PMID 27100738 DOI: 10.1371/journal.pcbi.1004873  0.36
2016 Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, et al. The state of melanoma: challenges and opportunities. Pigment Cell & Melanoma Research. PMID 27087480 DOI: 10.1111/pcmr.12475  0.32
2016 Kline CN, Joseph NM, Grenert JP, van Ziffle J, Yeh I, Bastian BC, Mueller S, Solomon DA. Inactivating MUTYH germline mutations in pediatric patients with high-grade midline gliomas. Neuro-Oncology. PMID 26902849 DOI: 10.1093/neuonc/now013  0.32
2015 Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, Dummer R, North J, Pincus L, Ruben B, Rickaby W, D'Arrigo C, Robson A, Bastian BC. The Genetic Evolution of Melanoma from Precursor Lesions. The New England Journal of Medicine. 373: 1926-36. PMID 26559571 DOI: 10.1056/NEJMoa1502583  0.32
2015 Shain AH, Garrido M, Botton T, Talevich E, Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, Thompson JF, Wiesner T, Roy R, Olshen AB, Gagnon A, ... ... Bastian BC, et al. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nature Genetics. PMID 26343386 DOI: 10.1038/ng.3382  0.36
2015 Conde-Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, Viros A, Gesbert F, Delmas V, Rambow F, Bastian BC, Campbell AD, Colombo S, Puig I, Bellacosa A, et al. A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity. Nature Communications. 6: 8093. PMID 26307673 DOI: 10.1038/ncomms9093  0.32
2015 Sanborn JZ, Chung J, Purdom E, Wang NJ, Kakavand H, Wilmott JS, Butler T, Thompson JF, Mann GJ, Haydu LE, Saw RP, Busam KJ, Lo RS, Collisson EA, Hur JS, ... ... Bastian BC, et al. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination. Proceedings of the National Academy of Sciences of the United States of America. PMID 26286987 DOI: 10.1073/pnas.1508074112  0.32
2015 Menzies AM, Yeh I, Botton T, Bastian BC, Scolyer RA, Long GV. Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion. Pigment Cell & Melanoma Research. 28: 607-10. PMID 26072686 DOI: 10.1111/pcmr.12388  0.32
2015 Yeh I, Botton T, Talevich E, Shain AH, Sparatta AJ, de la Fouchardiere A, Mully TW, North JP, Garrido MC, Gagnon A, Vemula SS, McCalmont TH, LeBoit PE, Bastian BC. Activating MET kinase rearrangements in melanoma and Spitz tumours. Nature Communications. 6: 7174. PMID 26013381 DOI: 10.1038/ncomms8174  0.36
2015 Carvajal RD, Lawrence DP, Weber JS, Gajewski TF, Gonzalez R, Lutzky J, O'Day SJ, Hamid O, Wolchok JD, Chapman PB, Sullivan RJ, Teitcher JB, Ramaiya N, Giobbie-Hurder A, Antonescu CR, ... ... Bastian BC, et al. Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2289-96. PMID 25695690 DOI: 10.1158/1078-0432.CCR-14-1630  0.32
2015 Yeh I, de la Fouchardiere A, Pissaloux D, Mully TW, Garrido MC, Vemula SS, Busam KJ, LeBoit PE, McCalmont TH, Bastian BC. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions. The American Journal of Surgical Pathology. 39: 581-91. PMID 25602801 DOI: 10.1097/PAS.0000000000000387  0.32
2015 Luke JJ, Triozzi PL, McKenna KC, Van Meir EG, Gershenwald JE, Bastian BC, Gutkind JS, Bowcock AM, Streicher HZ, Patel PM, Sato T, Sossman JA, Sznol M, Welch J, Thurin M, et al. Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell & Melanoma Research. 28: 135-47. PMID 25113308 DOI: 10.1111/pcmr.12304  0.32
2014 Botton T, Yeh I, Bastian BC. Melanoma BRAF fusions--letter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6631. PMID 25512635 DOI: 10.1158/1078-0432.CCR-14-0058  0.32
2014 Lowdon RF, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, Sigaroudinia M, Farnham PJ, Bastian BC, Tlsty TD, Marra MA, Hirst M, Costello JF, Wang T, Cheng JB. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nature Communications. 5: 5442. PMID 25421844 DOI: 10.1038/ncomms6442  0.32
2014 Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, Zhao L, Peyman G, Ouyang H, Jiang W, Zhao J, Chen X, Zhang L, Wang CY, Bastian BC, et al. Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell. 25: 822-30. PMID 24882516 DOI: 10.1016/j.ccr.2014.04.017  0.32
2014 Yeh I, Mully TW, Wiesner T, Vemula SS, Mirza SA, Sparatta AJ, McCalmont TH, Bastian BC, LeBoit PE. Ambiguous melanocytic tumors with loss of 3p21. The American Journal of Surgical Pathology. 38: 1088-95. PMID 24705312 DOI: 10.1097/PAS.0000000000000209  0.32
2014 North JP, Garrido MC, Kolaitis NA, LeBoit PE, McCalmont TH, Bastian BC. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases. The American Journal of Surgical Pathology. 38: 824-31. PMID 24618603 DOI: 10.1097/PAS.0000000000000189  0.32
2014 Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I, Lipson D, Otto G, Brennan K, Murali R, Garrido M, Miller VA, Ross JS, Berger MF, Sparatta A, ... ... Bastian BC, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nature Communications. 5: 3116. PMID 24445538 DOI: 10.1038/ncomms4116  0.32
2014 North JP, Vemula SS, Bastian BC. Chromosomal copy number analysis in melanoma diagnostics. Methods in Molecular Biology (Clifton, N.J.). 1102: 199-226. PMID 24258981 DOI: 10.1007/978-1-62703-727-3_12  0.32
2014 Simpson RM, Bastian BC, Michael HT, Webster JD, Prasad ML, Conway CM, Prieto VM, Gary JM, Goldschmidt MH, Esplin DG, Smedley RC, Piris A, Meuten DJ, Kiupel M, Lee CC, et al. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell & Melanoma Research. 27: 37-47. PMID 24128326 DOI: 10.1111/pcmr.12185  0.32
2013 Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell & Melanoma Research. 26: 845-51. PMID 23890088 DOI: 10.1111/pcmr.12148  0.32
2013 Yeh I, von Deimling A, Bastian BC. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. Journal of the National Cancer Institute. 105: 917-9. PMID 23690527 DOI: 10.1093/jnci/djt119  0.32
2012 Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. The American Journal of Surgical Pathology. 36: 818-30. PMID 22367297 DOI: 10.1097/PAS.0b013e3182498be5  0.32
2012 Murali R, Wiesner T, Rosenblum MK, Bastian BC. GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathologica. 123: 457-9. PMID 22307269 DOI: 10.1007/s00401-012-0948-x  0.32
2012 Minor DR, Kashani-Sabet M, Garrido M, O'Day SJ, Hamid O, Bastian BC. Sunitinib therapy for melanoma patients with KIT mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1457-63. PMID 22261812 DOI: 10.1158/1078-0432.CCR-11-1987  0.32
2012 McCalmont TH, Bastian BC. An unconventional deep penetrating melanocytic nevus with microscopic involvement of regional lymph nodes. Journal of Cutaneous Pathology. 39: 25-8. PMID 22211333 DOI: 10.1111/j.1600-0560.2011.01850.x  0.32
2012 Daud A, Bastian BC. Beyond BRAF in melanoma. Current Topics in Microbiology and Immunology. 355: 99-117. PMID 21826607 DOI: 10.1007/82_2011_163  0.32
2011 Ahronowitz IZ, Daud AI, Leong SP, Shue EH, Bastian BC, McCalmont TH, Yu SS. An isolated Merkel cell carcinoma metastasis at a distant cutaneous site presenting as a second 'primary' tumor. Journal of Cutaneous Pathology. 38: 801-7. PMID 21883364 DOI: 10.1111/j.1600-0560.2011.01757.x  0.32
2011 Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rütten A, ... ... Bastian BC, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nature Genetics. 43: 1018-21. PMID 21874003 DOI: 10.1038/ng.910  0.32
2011 Jalas JR, Vemula S, Bezrookove V, Leboit PE, Simko JP, Bastian BC. Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma. The American Journal of Surgical Pathology. 35: 1413-8. PMID 21836492 DOI: 10.1097/PAS.0b013e31822280d8  0.32
2011 North JP, Vetto JT, Murali R, White KP, White CR, Bastian BC. Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma. The American Journal of Surgical Pathology. 35: 1146-50. PMID 21716079 DOI: 10.1097/PAS.0b013e318222a634  0.32
2011 McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. Journal of Cutaneous Pathology. 38: 324-6, 323. PMID 21323719 DOI: 10.1111/j.1600-0560.2011.01674_2.x  0.32
2010 Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, ... ... Bastian BC, et al. Mutations in GNA11 in uveal melanoma. The New England Journal of Medicine. 363: 2191-9. PMID 21083380 DOI: 10.1056/NEJMoa1000584  0.32
2010 Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, Ridd K, Vogel H, Bastian BC, Attardi LD. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. Plos Genetics. 6: e1001168. PMID 20975948 DOI: 10.1371/journal.pgen.1001168  0.32
2010 Flaherty KT, Hodi FS, Bastian BC. Mutation-driven drug development in melanoma Current Opinion in Oncology. 22: 178-183. PMID 20401974 DOI: 10.1097/CCO.0b013e32833888ee  0.32
2010 Dalton SR, Gerami P, Kolaitis NA, Charzan S, Werling R, LeBoit PE, Bastian BC. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. The American Journal of Surgical Pathology. 34: 231-7. PMID 20087158 DOI: 10.1097/PAS.0b013e3181c805c4  0.32
2009 Yeh I, Bastian BC. Genome-wide associations studies for melanoma and nevi. Pigment Cell & Melanoma Research. 22: 527-8. PMID 19686382 DOI: 10.1111/j.1755-148X.2009.00622.x  0.32
2009 Harradine KA, Ridd K, Saunier EF, Clermont FF, Perez-Losada J, Moore DH, Epstein EH, Bastian BC, Akhurst RJ. Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5101-7. PMID 19671862 DOI: 10.1158/1078-0432.CCR-08-3286  0.32
2009 Gerami P, Jewell SS, Morrison LE, Blondin B, Schulz J, Ruffalo T, Matushek P, Legator M, Jacobson K, Dalton SR, Charzan S, Kolaitis NA, Guitart J, Lertsbarapa T, Boone S, ... ... Bastian BC, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. The American Journal of Surgical Pathology. 33: 1146-56. PMID 19561450 DOI: 10.1097/PAS.0b013e3181a1ef36  0.32
2009 Cronin JC, Wunderlich J, Loftus SK, Prickett TD, Wei X, Ridd K, Vemula S, Burrell AS, Agrawal NS, Lin JC, Banister CE, Buckhaults P, Rosenberg SA, Bastian BC, Pavan WJ, et al. Frequent mutations in the MITF pathway in melanoma. Pigment Cell & Melanoma Research. 22: 435-44. PMID 19422606 DOI: 10.1111/j.1755-148X.2009.00578.x  0.32
2009 Gartside MG, Chen H, Ibrahimi OA, Byron SA, Curtis AV, Wellens CL, Bengston A, Yudt LM, Eliseenkova AV, Ma J, Curtin JA, Hyder P, Harper UL, Riedesel E, Mann GJ, ... ... Bastian BC, et al. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Molecular Cancer Research : McR. 7: 41-54. PMID 19147536 DOI: 10.1158/1541-7786.MCR-08-0021  0.32
2009 Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 457: 599-602. PMID 19078957 DOI: 10.1038/nature07586  0.32
2008 Freedberg DE, Rigas SH, Russak J, Gai W, Kaplow M, Osman I, Turner F, Randerson-Moor JA, Houghton A, Busam K, Timothy Bishop D, Bastian BC, Newton-Bishop JA, Polsky D. Frequent p16-independent inactivation of p14ARF in human melanoma Journal of the National Cancer Institute. 100: 784-795. PMID 18505964 DOI: 10.1093/jnci/djn157  0.32
2008 Fargnoli MC, Fargnoli MC, Pike K, Pfeiffer RM, Tsang S, Rozenblum E, Munroe DJ, Golubeva Y, Calista D, Seidenari S, Massi D, Carli P, Bauer J, Elder DE, Bastian BC, et al. MC1R variants increase risk of melanomas harboring BRAF mutations. The Journal of Investigative Dermatology. 128: 2485-90. PMID 18368129 DOI: 10.1038/jid.2008.67  0.32
2008 North JP, Kageshita T, Pinkel D, LeBoit PE, Bastian BC. Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. The Journal of Investigative Dermatology. 128: 2024-30. PMID 18323782 DOI: 10.1038/jid.2008.41  0.36
2007 Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M, Denat L, Goodall J, Luciani F, Viros A, Demirkan N, Bastian BC, Goding CR, Larue L. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes & Development. 21: 2923-35. PMID 18006687 DOI: 10.1101/gad.450107  0.32
2006 Dumaz N, Hayward R, Martin J, Ogilvie L, Hedley D, Curtin JA, Bastian BC, Springer C, Marais R. In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Research. 66: 9483-91. PMID 17018604 DOI: 10.1158/0008-5472.CAN-05-4227  0.32
2006 Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, Kaufman RJ, Bastian BC, Soengas MS. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nature Cell Biology. 8: 1053-63. PMID 16964246 DOI: 10.1038/ncb1471  0.32
2005 Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian BC. Distinct sets of genetic alterations in melanoma. The New England Journal of Medicine. 353: 2135-47. PMID 16291983 DOI: 10.1056/NEJMoa050092  0.32
2005 Maize JC, McCalmont TH, Carlson JA, Busam KJ, Kutzner H, Bastian BC. Genomic analysis of blue nevi and related dermal melanocytic proliferations. The American Journal of Surgical Pathology. 29: 1214-20. PMID 16096412  0.32
2004 Hantschke M, Bastian BC, LeBoit PE. Consumption of the epidermis: a diagnostic criterion for the differential diagnosis of melanoma and Spitz nevus. The American Journal of Surgical Pathology. 28: 1621-5. PMID 15577682  0.32
2003 Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC. Determinants of BRAF mutations in primary melanomas. Journal of the National Cancer Institute. 95: 1878-90. PMID 14679157  0.32
2003 Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. The American Journal of Pathology. 163: 1765-70. PMID 14578177 DOI: 10.1016/S0002-9440(10)63536-5  0.32
2003 Dalton SR, Fillman EP, Altman CE, Gardner TL, Davis TL, Bastian BC, Libow LF, Elston DM. Atypical junctional melanocytic proliferations in benign lichenoid keratosis. Human Pathology. 34: 706-9. PMID 12874767 DOI: 10.1016/S0046-8177(03)00234-X  0.32
2002 Buckley PG, Mantripragada KK, Benetkiewicz M, Tapia-Páez I, Diaz De StÃ¥hl T, Rosenquist M, Ali H, Jarbo C, De Bustos C, Hirvelä C, Sinder Wilén B, Fransson I, Thyr C, Johnsson BI, Bruder CE, ... ... Bastian BC, et al. A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. Human Molecular Genetics. 11: 3221-9. PMID 12444106  0.32
2002 Bastian BC, Xiong J, Frieden IJ, Williams ML, Chou P, Busam K, Pinkel D, LeBoit PE. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. The American Journal of Pathology. 161: 1163-9. PMID 12368190 DOI: 10.1016/S0002-9440(10)64393-3  0.32
2002 Harvell JD, Bastian BC, LeBoit PE. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. The American Journal of Surgical Pathology. 26: 654-61. PMID 11979096  0.32
2002 You MJ, Castrillon DH, Bastian BC, O'Hagan RC, Bosenberg MW, Parsons R, Chin L, DePinho RA. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proceedings of the National Academy of Sciences of the United States of America. 99: 1455-60. PMID 11818530 DOI: 10.1073/pnas.022632099  0.32
Show low-probability matches.